Eliglustat Interactions
There are 328 drugs known to interact with eliglustat, along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 106 are major, 217 are moderate, and 5 are minor.
- View all 328 medications that may interact with eliglustat
- View eliglustat alcohol/food interactions (1)
- View eliglustat disease interactions (3)
Most frequently checked interactions
View interaction reports for eliglustat and the medicines listed below.
- Aldurazyme (laronidase)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Elelyso (taliglucerase alfa)
- Elfabrio (pegunigalsidase alfa)
- Ethyl Alcohol (ethanol)
- Fabrazyme (agalsidase beta)
- Fintepla (fenfluramine)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- L-Arginine (arginine)
- L-Carnitine (levocarnitine)
- L-Cysteine (cysteine)
- Lithium Carbonate ER (lithium)
- Opfolda (miglustat)
- Pombiliti (cipaglucosidase alfa)
- Quercetin (bioflavonoids)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Sotalol Hydrochloride AF (sotalol)
- Tramadol Hydrochloride ER (tramadol)
- Valproate Sodium (valproic acid)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin D3 (cholecalciferol)
- Vitamin K (phytonadione)
- Vitamin K2 (menaquinone)
- VPRIV (velaglucerase alfa)
Eliglustat alcohol/food interactions
There is 1 alcohol/food interaction with eliglustat.
Eliglustat disease interactions
There are 3 disease interactions with eliglustat which include:
More about eliglustat
- eliglustat consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.